logo
  

Qualcomm Names Don McGuire New Chief Marketing Officer

Wireless technology innovator Qualcomm Incorporated (QCOM) on Monday said it appointed Don McGuire as its new chief marketing officer (CMO) with immediate effect, replacing Penny Baldwin , who will continue to be in an advisory role until retirement later in the year.


McGuire joined Qualcomm in 2016 as vice president of Global Product Marketing and was promoted to senior vice president last year with responsibility for Snapdragon marketing. McGuire is credited with launching innovative marketing campaigns, for redefining the strategic approach to product marketing and for collaborative partnerships that brought the most cutting-edge products to market, including the latest in 5G technologies.


His 25- year long experience spanned the service provider, device OEM, content / applications, and semiconductor industries. Prior to Qualcomm, McGuire was associated with Intel's global marketing strategy and campaigns.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT